The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data

INTRODUCTION: Little is known about the burden of hereditary transthyretin (ATTRv) amyloidosis, a genetic, progressive, and fatal disease caused by extracellular deposition of transthyretin amyloid fibrils. The study’s aim was to estimate costs and disease burden associated with ATTRv amyloidosis in...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Sheila R., Chang, Eunice, Tarbox, Marian H., Broder, Michael S., Tieu, Ryan S., Guthrie, Spencer, Vera-Llonch, Montserrat, Pollock, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606386/
https://www.ncbi.nlm.nih.gov/pubmed/32451849
http://dx.doi.org/10.1007/s40120-020-00194-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606386/
https://www.ncbi.nlm.nih.gov/pubmed/32451849
http://dx.doi.org/10.1007/s40120-020-00194-4

Ejemplares similares